Lineage Cell Therapeutics Inc (LCTX)

[pymadams]

What was the IFATS data.
It's a little frustrating that there's no information I can find about the data presented to IFATS. My understanding is that Ramon Lull injected more of the "product" than the tests in the USA.
The company talks about licensing Renevia in Europe before America and also as a cosmetic solution versus just fat loss. So the info from Ramon would be doubly interesting. It's also about 6 months since he started the trial so his information should have been interesting.

The IFATS data could have been disappointing, in which case I feel that information would have become known in the wider arena. The data could have exceeded expectations, in which case that would also have been known. I know nothing so I'm expecting that it was inline with expectations. If that's the case I would still have expected some kind of excitement about the data, unless there are many other competing technologies and Renevia is just a "me too".

I'm a long term holder in these shares.